Sphingosine-1-Phosphate Metabolism and Signaling in Kidney Diseases
- 18 December 2020
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Society of Nephrology
- Vol. 32 (1), 9-31
- https://doi.org/10.1681/asn.2020050697
Abstract
In the past few decades, sphingolipids and sphingolipid metabolites have gained attention because of their essential role in the pathogenesis and progression of kidney diseases. Studies in models of experimental and clinical nephropathies have described accumulation of sphingolipids and sphingolipid metabolites, and it has become clear that the intracellular sphingolipid composition of renal cells is an important determinant of renal function. Proper function of the glomerular filtration barrier depends heavily on the integrity of lipid rafts, which include sphingolipids as key components. In addition to contributing to the structural integrity of membranes, sphingolipid metabolites, such as sphingosine-1-phosphate (S1P), play important roles as second messengers regulating biologic processes, such as cell growth, differentiation, migration, and apoptosis. This review will focus on the role of S1P in renal cells and how aberrant extracellular and intracellular S1P signaling contributes to the pathogenesis and progression of kidney diseases.Keywords
Funding Information
- National Center for Advancing Translational Sciences (grant UL1TR002736)
- National Institutes of Health (R01DK117599, R01DK104753, R01CA227493)
- F. Hoffmann-La Roche
- Boehringer Ingelheim
- National Institutes of Health (U54DK083912, UM1DK100846, U01DK116101)
- National Institute on Minority Health and Health Disparities (UL1TR000460)
This publication has 223 references indexed in Scilit:
- Sphingolipid Metabolism Cooperates with BAK and BAX to Promote the Mitochondrial Pathway of ApoptosisCell, 2012
- Sphingosine-1-phosphate signaling and its role in diseaseTrends in Cell Biology, 2012
- Sphingosine kinase 1 localized to the plasma membrane lipid raft microdomain overcomes serum deprivation induced growth inhibitionArchives of Biochemistry and Biophysics, 2009
- Transforming growth factor-β2 upregulates sphingosine kinase-1 activity, which in turn attenuates the fibrotic response to TGF-β2 by impeding CTGF expressionKidney International, 2009
- Divergent roles of sphingosine kinases in kidney ischemia–reperfusion injuryKidney International, 2009
- The Spinster Homolog, Two of Hearts, Is Required for Sphingosine 1-Phosphate Signaling in ZebrafishCurrent Biology, 2008
- Increased survival and reduced renal injury in MRL/lpr mice treated with a novel sphingosine-1-phosphate receptor agonistKidney International, 2008
- The vascular S1P gradient—Cellular sources and biological significanceBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2008
- Sphingosine-1-phosphate receptors: Biology and therapeutic potential in kidney diseaseKidney International, 2008
- A novel method to quantify sphingosine 1-phosphate by immobilized metal affinity chromatography (IMAC)Prostaglandins & Other Lipid Mediators, 2007